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Accelerated Coronary Plaque
Progression and Endothelial
Dysfunction
Serial Volumetric Evaluation by IVUS
Although atherosclerosis is a systemic disease, plaque progression
and complications occur in a focal, patchy pattern. It remains
challenging to predict which segments of a given coronary artery will
show accelerated progression of atherosclerosis.
Coronary endothelial dysfunction, characterized by a segmental
vasoconstrictive response to the endothelium-dependent vasodilator
acetylcholine, is considered the earliest stage of atherosclerosis in pa-
tients with angiographically nonobstructive coronary arteries. There-
fore, sites with endothelial dysfunction may signal future progression
of segmental coronary atherosclerosis (1). Using serial intravascular
ultrasound (IVUS) imaging, we tested the hypothesis that coronary
segments with endothelial dysfunction are associated with plaque
progression in patients with nonobstructive coronary artery disease.
In this prospective study, 22 patients underwent coronary angiog-
raphy with coronary endothelial function assessment and IVUS for
clinical purposes at baseline and at 6 months (all 22 patients werepart of the placebo groups of the prospective National Institutes of
Health–sponsored studies: the Correlation of Endothelial Function
and Early Coronary Artery Disease in Humans trial [NCT00271492]
and the Long-Term l-Arginine Supplementation Improves Small-
Vessel Coronary Endothelial Function in Humans trial [HL-03180-
01]). Coronary artery segments with normal (n ¼ 22) and abnormal
(n ¼ 22) endothelial function were analyzed within the same subject
and compared with each other after 6 months of follow-up.
Endothelium-dependent and -independent vasoreactivity
was assessed as previously described (1,2). After completing
the endothelial function studies, standard IVUS analysis
with automated pullback (0.5 mm/s) of the left anterior descending
coronary artery was performed using a 20-MHz, 2.9-F Eagle Eye
catheter (Volcano Corporation, Rancho Cordova, California).
Comparisons between measurements on segments with versus
without endothelial dysfunction were conducted using Wilcoxon
signed rank tests, because each patient contributed 1 segment
of each kind. Similarly, comparisons between baseline and
6-month follow-up measures were conducted using Wilcoxon
signed rank tests. All statistical tests were 2-sided, and a p value
<0.05 was considered to be statistically signiﬁcant. Analyses were
conducted using SAS version 9.2 (SAS Institute, Cary, North
Carolina) and SPSS version 11.5 (IBM, Armonk, New York).
There was a signiﬁcant decrease in total and low-density
lipoprotein cholesterol, as well as C-reactive protein levels at 6-
month follow-up without a signiﬁcant change in statin use. Lifestyle
changes that may have contributed to these changes were not
assessed in the current study protocol.
Intraindividual percent change of normalized total atheroma vol-
ume (TAV) and percent change of percent atheroma volume (PAV)
of the segments with endothelial dysfunction were higher than of
those with normal endothelial function, reaching statistical signiﬁ-
cance only for changes in PAV (Fig. 1). Although there was signif-
icant increase in plaque volume in the segments with endothelial
dysfunction, lumen size did not change signiﬁcantly. Although the
presence of endothelial dysfunction was associated with coronary
plaque progression, there was no signiﬁcant correlation between the
degree of percent change of epicardial segmental coronary arterial
diameter with acetylcholine infusion during follow-up and percent
change of normalized TAV (r ¼ 0.24, p ¼ 0.40). Likewise, there
was no signiﬁcant correlation between percent change of coronary
blood ﬂow with acetylcholine during follow-up and percent change of
normalized TAV (r ¼ 0.18, p ¼ 0.52).
The current study, thus, demonstrates for the ﬁrst time in pa-
tients with mild coronary artery disease using serial volumetric IVUS
analysis that, within the same coronary artery, segments with
endothelial dysfunction show accelerated plaque progression
compared with segments with normal endothelial function.
Our ﬁndings expand previous observations and suggest a regional
association between coronary endothelial dysfunction and progres-
sion of coronary atherosclerosis.
We have previously reported that coronary artery segments with
endothelial dysfunction have larger necrotic cores and more features
of plaque vulnerability including microcalciﬁcation as assessed by
virtual histology (VH) (3). In addition, the most-recent data from
the PROSPECT (Providing Regional Observations to Study
Predictors of Events in the Coronary Tree) study in patients with
acute coronary syndromes demonstrated that nonculprit lesions with
Figure 1. Comparison of Intraindividual % Change of Normalized PAV and
TAV Between the Segments With Endothelial Dysfunction and Those
With Normal Endothelial Function
The % change of normalized percent atheroma volume (PAV) is shown in the
upper left panel and of total atheroma volume (TAV) in the upper right
panel. The comparison is between segments with endothelial dysfunction and
those with normal endothelial function. Representative examples of intravas-
cular ultrasound (IVUS) ﬁndings are shown in the lower panel. Segments with
endothelial dysfunction showed greater progression in PAV (*p < 0.05) and
TAV (p ¼ 0.065) than segments with normal endothelial function from the
same subject. IVUS demonstrates the progression of disease-only segments
with endothelial dysfunction (lumen traced in green, external elastic mem-
brane in yellow).
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10470% plaque burden and IVUS-VH–derived thin-capped ﬁbroa-
theroma are more likely associated with the progression of athero-
sclerosis and recurrent coronary events (4). Thus, the current study
extends these previous observations and demonstrates that coronary
artery segments with relatively small plaque burden, but evidence of
endothelial dysfunction, show faster plaque progression over a rela-
tively short period of time than segmentswith similar plaque burden at
baseline, but normal endothelial function. Thus, segments with
endothelial dysfunction may represent the earliest identiﬁable site
with underlying vascular injury, but abnormal repair prone to accel-
erated plaque progression and complications.
The mechanism for plaque progression at the segments with
endothelial dysfunction may be multifactorial, but the reduced activity
of endothelium-dependent vasodilators, particularly nitric oxideactivity, an increased activity of vasoconstrictors with mitogenic ac-
tivity, and altered anti-inﬂammatory and anticoagulant properties of
the endothelium likely contribute to accelerated plaque progression.
The lack of correlation between the severity of endothelial
dysfunction and plaque progression suggests that plaque progression
is independent of changes in the degree of coronary endothelial
reactivity.
In conclusion, atherosclerosis is a diffuse and systemic disease
with focal complications. The ability of in vivo identiﬁcation of
coronary artery segments with propensity for plaque vulnerability
that are at risk for plaque progression and the development of car-
diovascular events may potentially have implications for future site-
speciﬁc therapy beyond the systemic therapy for patients in early
coronary atherosclerosis.
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Deﬁnitions of Outcome, Response
and Effect in Imaging Research to
Avoid Confusion
“Outcome,” “response,” and “effect” are not the same. Unfortunately,
these terms are commonly used interchangeably in imaging research,
which can lead to problems with study design and misinterpretation
of results. We propose and illustrate simple deﬁnitions to allow these
fundamentally different concepts to be distinguished for clear
communication between authors and readers of scientiﬁc papers.
OUTCOME
“Outcome” is a measured value, which can be a state of health or an
event, subsequent to an intervention. Outcome data is easy to
